Provided by Tiger Trade Technology Pte. Ltd.

Impact Biomedical, Inc.

5.32
-0.1099-2.02%
Post-market: 5.550.2299+4.32%16:22 EDT
Volume:11.55K
Turnover:62.23K
Market Cap:45.53M
PE:60.22
High:5.54
Open:5.54
Low:5.27
Close:5.43
52wk High:10.47
52wk Low:4.67
Shares:8.56M
Float Shares:910.31K
Volume Ratio:1.11
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0883
EPS(LYR):-4.7956
ROE:23.46%
ROA:-17.79%
PB:4.23
PE(LYR):-1.11

Loading ...

Guangzhou Zhonghuang Hong Kong-Macau Children's School Strengthens Its Foundation Through Accredited Status and Quality Assurance

Deep News
·
Sep 24

Impact Biomedical Inc trading resumes

TIPRANKS
·
Sep 23

Amex Halt Add Info Lst 5.800000

THOMSON REUTERS
·
Sep 23

Impact BioMedical advances merger with Zoar Limited

TIPRANKS
·
Sep 17

Press Release: DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical's Proposed Business Combination with Zoar Limited

Dow Jones
·
Sep 16

Impact Biomedical Says Zoar Files SEC F-4 for Proposed Merger

Reuters
·
Sep 16

Impact BioMedical Announces Reverse Split to Support Merger

TIPRANKS
·
Sep 15

Impact Biomedical to Execute 1-for-12.62 Reverse Stock Split Sept. 23

Reuters
·
Sep 15

Corrected — Impact Biomedical Inc (Nyse: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (F/K/a DR Ashleys Limited)

THOMSON REUTERS
·
Sep 15

Impact BioMedical announces 1 for 12.62 reverse stock split

TIPRANKS
·
Sep 12

Impact BioMedical to Consolidate Shares in 1-for-12.62 Reverse Stock Split on Sept. 23

Reuters
·
Sep 12

Impact Biomedical Inc (Nyse American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (Previously DR. Ashley’s Ltd.)

THOMSON REUTERS
·
Sep 12

Impact Biomedical - Reverse Stock Split Effective September 23, 2026

THOMSON REUTERS
·
Sep 12

Impact Biomedical Q2 FY26 Net Loss Narrows 95% to $700,000

Reuters
·
Aug 08

Impact BioMedical Q1 EPS $(0.02) Up From $(0.11) YoY, Sales $7.000K

Benzinga Earnings
·
May 13

Impact BioMedical Q1 FY26 net loss widens 79% to $2.28 million

Reuters
·
May 13

Impact Biomedical CFO Todd Macko disposes shares worth $25k

Reuters
·
Mar 31